Exhibit 99.1

DANAHER REPORTS FOURTH QUARTER AND FULL YEAR 2008 RESULTS
WASHINGTON, D.C., January 26, 2009 — Danaher Corporation (NYSE:DHR) announced results for the fourth quarter and year ended December 31, 2008. Net earnings for the fourth quarter were $305.7 million, or $0.92 per diluted share. Included in the fourth quarter results are certain non-cash charges related to the acquisition of Tektronix for fair value adjustments to recorded inventory and deferred revenue which reduced net earnings by approximately $5 million or $0.01 per diluted share, as well as after-tax charges of approximately $62 million or $0.18 per diluted share related to previously announced restructuring activities. Absent these two items, adjusted earnings per diluted share was $1.11, essentially flat versus last year’s adjusted earnings per diluted share from continuing operations of $1.12.
Sales from continuing operations for the 2008 fourth quarter were $3.18 billion, 1% higher than the $3.14 billion reported for the 2007 fourth quarter.
Net earnings for the full year 2008 were $1.3 billion, or $3.95 per diluted share. Included in the full year 2008 earnings per diluted share are the fourth quarter 2008 items noted above, as well as the non-cash charges recorded in the first three quarters of 2008 related to the acquisition of Tektronix for fair value adjustments to recorded inventory and deferred revenue which reduced net earnings by approximately $0.12 per diluted share and gains from the net reduction in income tax reserves and discrete tax benefits of approximately $0.03 per diluted share. Absent these items, adjusted earnings per diluted share were $4.23, an increase of 10.5% compared to the 2007 full year adjusted earnings per diluted share from continuing operations of $3.83.
Sales from continuing operations for 2008 were $12.7 billion compared to $11 billion for 2007, an increase of 15%.
Attached is a reconciliation of adjusted diluted net earnings per share from continuing operations to diluted net earnings per share from continuing operations calculated according to GAAP, for the three and twelve month periods ended December 31, 2008 and the comparable prior year periods.
H. Lawrence Culp, Jr., President and Chief Executive Officer, stated, “The dramatic downturn in the global economy in the latter part of 2008 negatively impacted a number of our businesses, our end markets and our customers. In spite of these unprecedented headwinds we were able to deliver a solid 2008 performance. Core revenues decreased 1% in the quarter and increased 2.5% for the full year. Operating cash flow from continuing operations in 2008 was a record $1.9 billion, representing a 9.5% increase over our record 2007 performance. While we expect 2009 to be a difficult year, we believe our solid portfolio of businesses, our strong balance sheet and the Danaher Business System will provide our experienced team the opportunity to outperform.”
Danaher Corporation is a leading manufacturer of Professional Instrumentation, Medical Technologies, Industrial Technologies, and Tools and Components (www.danaher.com).
Statements in this release that are not strictly historical, including the statements regarding expectations for 2009 and any other statements regarding events or developments that we believe or anticipate will or may occur in the future, may be “forward-looking” statements. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements. These factors include, among other things, the current economic recession and the
1
upheaval in the credit markets and financial services industry, competition, our ability to develop and successfully market new products and technologies, our ability to expand our business in new markets, our ability to identify, consummate and integrate appropriate acquisitions, litigation and other contingent liabilities including intellectual property and environmental matters, our compliance with applicable laws and regulations and changes in applicable laws and regulations, tax audits and changes in our tax rate, currency exchange rates, commodity costs and surcharges, our relationships with and the performance of our channel partners, our ability to achieve projected efficiencies, cost reductions, sales growth and earnings, economic and other conditions in the end-markets we sell into, and general domestic and international economic conditions. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our 2007 Annual Report on Form 10-K and Third Quarter 2008 Quarterly Report on Form 10-Q. These forward-looking statements speak only as of the date of this release and the Company does not assume any obligation or intend to update any forward-looking statement.
Please contact:
Andy Wilson
Vice President, Investor Relations
Danaher Corporation
2099 Pennsylvania Avenue
Washington, D.C. 20006
Telephone: (202) 828-0850
2
DANAHER CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EARNINGS
($ in thousands, except per share amounts)
| | | | | | | | | | | | | | | | |
| | Three Months Ended | | | Year Ended | |
| | 12/31/08 | | | 12/31/07 | | | 12/31/08 | | | 12/31/07 | |
Sales | | $ | 3,176,506 | | | $ | 3,141,177 | | | $ | 12,697,456 | | | $ | 11,025,917 | |
| | | | |
Operating costs and expenses: | | | | | | | | | | | | | | | | |
Cost of sales | | | 1,724,897 | | | | 1,690,647 | | | | 6,757,262 | | | | 5,985,022 | |
Selling, general and administrative expenses | | | 860,491 | | | | 769,178 | | | | 3,345,274 | | | | 2,713,097 | |
Research and development expenses | | | 167,467 | | | | 216,582 | | | | 725,443 | | | | 601,424 | |
Other (income) expense | | | — | | | | — | | | | — | | | | (14,335 | ) |
| | | | | | | | | | | | | | | | |
Total operating expenses | | | 2,752,855 | | | | 2,676,407 | | | | 10,827,979 | | | | 9,285,208 | |
| | | | |
Operating profit | | | 423,651 | | | | 464,770 | | | | 1,869,477 | | | | 1,740,709 | |
Interest expense | | | (25,433 | ) | | | (32,793 | ) | | | (130,174 | ) | | | (109,702 | ) |
Interest income | | | 4,000 | | | | 2,735 | | | | 10,004 | | | | 6,092 | |
| | | | | | | | | | | | | | | | |
Earnings from continuing operations before income taxes | | | 402,218 | | | | 434,712 | | | | 1,749,307 | | | | 1,637,099 | |
| | | | |
Income taxes | | | (96,532 | ) | | | (114,487 | ) | | | (431,676 | ) | | | (423,101 | ) |
| | | | | | | | | | | | | | | | |
Earnings from continuing operations | | | 305,686 | | | | 320,225 | | | | 1,317,631 | | | | 1,213,998 | |
| | | | |
Earnings from discontinued operations, net of income taxes | | | — | | | | — | | | | — | | | | 155,906 | |
| | | | | | | | | | | | | | | | |
| | | | |
Net earnings | | $ | 305,686 | | | $ | 320,225 | | | $ | 1,317,631 | | | $ | 1,369,904 | |
| | | | | | | | | | | | | | | | |
Earnings per share from continuing operations: | | | | | | | | | | | | | | | | |
Basic | | $ | 0.96 | | | $ | 1.02 | | | $ | 4.13 | | | $ | 3.90 | |
| | | | | | | | | | | | | | | | |
Diluted | | $ | 0.92 | | | $ | 0.97 | | | $ | 3.95 | | | $ | 3.72 | |
| | | | | | | | | | | | | | | | |
Earnings per share from discontinued operations: | | | | | | | | | | | | | | | | |
Basic | | | — | | | | — | | | | — | | | $ | 0.50 | |
| | | | | | | | | | | | | | | | |
Diluted | | | — | | | | — | | | | — | | | $ | 0.47 | |
| | | | | | | | | | | | | | | | |
Net earnings per share: | | | | | | | | | | | | | | | | |
Basic | | $ | 0.96 | | | $ | 1.02 | | | $ | 4.13 | | | $ | 4.40 | |
| | | | | | | | | | | | | | | | |
Diluted | | $ | 0.92 | | | $ | 0.97 | | | $ | 3.95 | | | $ | 4.19 | |
| | | | | | | | | | | | | | | | |
Average common stock and common equivalent shares outstanding: | | | | | | | | | | | | | | | | |
Basic | | | 319,523 | | | | 315,437 | | | | 319,361 | | | | 311,225 | |
Diluted | | | 333,593 | | | | 334,013 | | | | 335,863 | | | | 329,459 | |
This information is presented for reference only. Final audited financial statements will include footnotes, which should be referenced when available, to more fully understand the contents of this information.
3
DANAHER CORPORATION AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
As of December 31 ($ and shares in thousands)
| | | | | | | |
| | 2008 | | | 2007 |
ASSETS | | | | | | | |
| | |
Current Assets: | | | | | | | |
Cash and equivalents | | $ | 392,854 | | | $ | 239,108 |
Trade accounts receivable, less allowance for doubtful accounts of $120,730 and $108,781, respectively | | | 1,894,585 | | | | 1,984,384 |
Inventories | | | 1,142,309 | | | | 1,193,615 |
Prepaid expenses and other current assets | | | 757,371 | | | | 632,660 |
| | | | | | | |
Total current assets | | | 4,187,119 | | | | 4,049,767 |
Property, plant and equipment, net | | | 1,108,653 | | | | 1,108,634 |
Other assets | | | 432,257 | | | | 507,550 |
Goodwill | | | 9,210,581 | | | | 9,241,011 |
Other intangible assets, net | | | 2,519,422 | | | | 2,564,973 |
| | | | | | | |
Total assets | | $ | 17,458,032 | | | $ | 17,471,935 |
| | | | | | | |
LIABILITIES AND STOCKHOLDERS’ EQUITY | | | | | | | |
| | |
Current Liabilities: | | | | | | | |
Notes payable and current portion of long-term debt | | $ | 66,159 | | | $ | 330,480 |
Trade accounts payable | | | 1,108,961 | | | | 1,125,600 |
Accrued expenses and other liabilities | | | 1,534,575 | | | | 1,443,773 |
| | | | | | | |
Total current liabilities | | | 2,709,695 | | | | 2,899,853 |
| | |
Other long-term liabilities | | | 2,386,605 | | | | 2,090,630 |
Long-term debt | | | 2,553,170 | | | | 3,395,764 |
Stockholders’ equity: | | | | | | | |
Common stock—$0.01 par value, 1 billion shares authorized; 354,487 and 352,608 issued; 318,380 and 317,984 outstanding, respectively | | | 3,544 | | | | 3,526 |
Additional paid-in capital | | | 1,812,963 | | | | 1,718,716 |
Retained earnings | | | 8,095,155 | | | | 6,820,756 |
Accumulated other comprehensive income | | | (103,100 | ) | | | 542,690 |
| | | | | | | |
Total stockholders’ equity | | | 9,808,562 | | | | 9,085,688 |
| | | | | | | |
Total liabilities and stockholders’ equity | | $ | 17,458,032 | | | $ | 17,471,935 |
| | | | | | | |
This information is presented for reference only. Final audited financial statements will include footnotes, which should be referenced when available, to more fully understand the contents of this information.
4
DANAHER CORPORATION AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
Year Ended December 31 ($ in thousands)
| | | | | | | | |
| | 2008 | | | 2007 | |
Cash flows from operating activities: | | | | | | | | |
Net earnings | | $ | 1,317,631 | | | $ | 1,369,904 | |
Less: earnings from discontinued operations, net of tax | | | — | | | | 155,906 | |
| | | | | | | | |
Net earnings from continuing operations | | | 1,317,631 | | | | 1,213,998 | |
Non-cash items, net of the effect of discontinued operations: | | | | | | | | |
Depreciation | | | 193,997 | | | | 173,942 | |
Amortization | | | 145,290 | | | | 94,550 | |
Stock compensation expense | | | 86,000 | | | | 73,347 | |
Change in deferred income taxes | | | 27,691 | | | | 29,870 | |
Change in trade accounts receivable, net | | | 71,403 | | | | (72,555 | ) |
Change in inventories | | | 33,119 | | | | 38,094 | |
Change in accounts payable | | | 3,713 | | | | 103,800 | |
Change in prepaid expenses and other assets | | | (4,773 | ) | | | 38,601 | |
Change in accrued expenses and other liabilities | | | (15,042 | ) | | | 5,661 | |
| | | | | | | | |
Total operating cash flows from continuing operations | | | 1,859,029 | | | | 1,699,308 | |
Total operating cash flows from discontinued operations | | | — | | | | (53,533 | ) |
| | | | | | | | |
Net cash flows from operating activities | | | 1,859,029 | | | | 1,645,775 | |
| | | | | | | | |
Cash flows from investing activities: | | | | | | | | |
Payments for additions to property, plant and equipment | | | (193,783 | ) | | | (162,071 | ) |
Proceeds from disposals of property, plant and equipment | | | 1,088 | | | | 15,537 | |
Cash paid for acquisitions | | | (423,208 | ) | | | (3,576,562 | ) |
Cash paid for investment in acquisition target and other marketable securities | | | — | | | | (23,219 | ) |
Proceeds from sale of investment and divestitures | | | — | | | | 301,278 | |
Proceeds from refundable escrowed purchase price | | | 48,504 | | | | — | |
| | | | | | | | |
Total investing cash flows from continuing operations | | | (567,399 | ) | | | (3,445,037 | ) |
Total investing cash flows from discontinued operations | | | — | | | | (722 | ) |
| | | | | | | | |
Net cash used in investing activities | | | (567,399 | ) | | | (3,445,759 | ) |
| | | | | | | | |
Cash flows from financing activities: | | | | | | | | |
Proceeds from issuance of common stock | | | 82,430 | | | | 733,028 | |
Payment of dividends | | | (38,259 | ) | | | (34,275 | ) |
Purchase of treasury stock | | | (74,165 | ) | | | (117,486 | ) |
Net (repayments) proceeds of borrowings (maturities of 90 days or less) | | | (905,567 | ) | | | 647,761 | |
Proceeds of borrowings (maturities longer than 90 days) | | | 72,652 | | | | 493,705 | |
Repayments of borrowings (maturities longer than 90 days) | | | (259,344 | ) | | | (10,563 | ) |
| | | | | | | | |
Net cash (used in) generated by financing activities | | | (1,122,253 | ) | | | 1,712,170 | |
| | | | | | | | |
Effect of exchange rate changes on cash and equivalents | | | (15,631 | ) | | | 9,112 | |
| | | | | | | | |
Net change in cash and equivalents | | | 153,746 | | | | (78,702 | ) |
| | |
Beginning balance of cash and equivalents | | | 239,108 | | | | 317,810 | |
| | | | | | | | |
Ending balance of cash and equivalents | | $ | 392,854 | | | $ | 239,108 | |
| | | | | | | | |
This information is presented for reference only. Final audited financial statements will include footnotes, which should be referenced when available, to more fully understand the contents of this information.
5
DANAHER CORPORATION AND SUBSIDIARIES
SEGMENT INFORMATION
($ in thousands, unaudited)
| | | | | | | | | | | | | | | | |
| | Three Months Ended | | | Year Ended | |
| | 12/31/08 | | | 12/31/07 | | | 12/31/08 | | | 12/31/07 | |
Sales | | | | | | | | | | | | | | | | |
| | | | |
Professional Instrumentation | | $ | 1,243,949 | | | $ | 1,097,511 | | | $ | 4,860,764 | | | $ | 3,537,912 | |
Medical Technologies | | | 843,820 | | | | 866,311 | | | | 3,277,026 | | | | 2,997,986 | |
Industrial Technologies | | | 777,932 | | | | 812,435 | | | | 3,265,451 | | | | 3,153,377 | |
Tools & Components | | | 310,805 | | | | 364,920 | | | | 1,294,215 | | | | 1,336,642 | |
| | | | | | | | | | | | | | | | |
| | $ | 3,176,506 | | | $ | 3,141,177 | | | $ | 12,697,456 | | | $ | 11,025,917 | |
| | | | | | | | | | | | | | | | |
Operating Profit | | | | | | | | | | | | | | | | |
| | | | |
Professional Instrumentation | | $ | 221,960 | | | $ | 175,227 | | | $ | 907,254 | | | $ | 709,502 | |
Medical Technologies | | | 90,134 | | | | 132,863 | | | | 370,473 | | | | 393,230 | |
Industrial Technologies | | | 106,569 | | | | 132,046 | | | | 522,112 | | | | 532,477 | |
Tools & Components | | | 30,343 | | | | 43,211 | | | | 157,673 | | | | 175,634 | |
Other | | | (25,355 | ) | | | (18,577 | ) | | | (88,035 | ) | | | (70,134 | ) |
| | | | | | | | | | | | | | | | |
| | $ | 423,651 | | | $ | 464,770 | | | $ | 1,869,477 | | | $ | 1,740,709 | |
| | | | | | | | | | | | | | | | |
Operating Margins | | | | | | | | | | | | | | | | |
| | | | |
Professional Instrumentation | | | 17.8 | % | | | 16.0 | % | | | 18.7 | % | | | 20.1 | % |
Medical Technologies | | | 10.7 | % | | | 15.3 | % | | | 11.3 | % | | | 13.1 | % |
Industrial Technologies | | | 13.7 | % | | | 16.3 | % | | | 16.0 | % | | | 16.9 | % |
Tools & Components | | | 9.8 | % | | | 11.8 | % | | | 12.2 | % | | | 13.1 | % |
| | | | |
Total | | | 13.3 | % | | | 14.8 | % | | | 14.7 | % | | | 15.8 | % |
| | | | |
Restructuring & Other Related Charges | | | | | | | | | | | | | | | | |
| | | | |
Professional Instrumentation | | $ | 28,813 | | | | — | | | $ | 28,813 | | | | — | |
Medical Technologies | | | 26,081 | | | | — | | | | 26,081 | | | | — | |
Industrial Technologies | | | 23,093 | | | | — | | | | 23,093 | | | | — | |
Tools & Components | | | 3,978 | | | | — | | | | 3,978 | | | | — | |
| | | | | | | | | | | | | | | | |
Total | | $ | 81,965 | | | | — | | | $ | 81,965 | | | | — | |
| | | | | | | | | | | | | | | | |
Restructuring Cost Classification | | | | | | | | | | | | | | | | |
Cost of sales | | $ | 33,130 | | | | — | | | $ | 33,130 | | | | — | |
Selling, general and administrative expenses | | | 48,835 | | | | — | | | | 48,835 | | | | — | |
| | | | | | | | | | | | | | | | |
| | $ | 81,965 | | | | — | | | $ | 81,965 | | | | — | |
| | | | | | | | | | | | | | | | |
This information is presented for reference only. Final audited financial statements will include footnotes, which should be referenced when available, to more fully understand the contents of this information
6
Danaher Corporation
Supplemental Reconciliation of Net Earnings from Continuing Operations and Diluted Net Earnings
Per Share from Continuing Operations (GAAP) to Adjusted Net Earnings from Continuing
Operations and Adjusted Diluted Net Earnings Per Share from Continuing Operations (Non-GAAP)
Three Months and Years Ended December 31, 2008 and December 31, 2007
($ in 000’s except per share data)
| | | | | | | | | | | | | | | | | | | | | | |
| | Three Months Ended | | | | | | Years Ended | | | | |
| | December 31, 2008 | | | December 31, 2007 | | | % Change | | | December 31, 2008 | | | December 31, 2007 | | | % Change | |
Net Earnings from Continuing Operations per GAAP | | $ | 305,686 | | | $ | 320,225 | | | -4.5 | % | | $ | 1,317,631 | | | $ | 1,213,998 | | | 8.5 | % |
| | | | | | | | | | | | | | | | | | | | | | |
After-tax charges for purchased in-process research and development and fair value adjustments to recorded inventory and deferred revenue balances related to the acquisition of Tektronix ($6.9 million & $59.5 million pre-tax for the three months and year ended December 31, 2008, respectively, and $68.2 million for both the three months and year ended December 31, 2007) | | | 5,150 | | | | 66,000 | | | | | | | 44,465 | | | | 66,000 | | | | |
After-tax charge related to fourth quarter 2008 restructuring actions and related charges ($82.0 million pre-tax). | | | 61,500 | | | | — | | | | | | | 61,500 | | | | — | | | | |
Gains from net reduction in income tax reserves and discrete tax benefits | | | (1,160 | ) | | | (14,562 | ) | | | | | | (9,524 | ) | | | (21,084 | ) | | | |
After-tax gain on indemnity proceeds related to litigation matter ($12.5 million pre-tax) | | | — | | | | — | | | | | | | — | | | | (8,110 | ) | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Adjusted Net Earnings from Continuing Operations (Non-GAAP) | | $ | 371,176 | | | $ | 371,663 | | | -0.1 | % | | $ | 1,414,072 | | | $ | 1,250,804 | | | 13.1 | % |
| | | | | | | | | | | | | | | | | | | | | | |
Diluted Net Earnings Per Share from Continuing Operations per GAAP | | $ | 0.92 | | | $ | 0.97 | | | -5.2 | % | | $ | 3.95 | | | $ | 3.72 | | | 6.2 | % |
| | | | | | | | | | | | | | | | | | | | | | |
After-tax charges for purchased in-process research and development and fair value adjustments to recorded inventory and deferred revenue balances related to the acquisition of Tektronix ($6.9 million & $59.5 million pre-tax for the three months and year ended December 31, 2008, respectively, and $68.2 million for both the three months and year ended December 31, 2007) | | | 0.01 | | | | 0.20 | | | | | | | 0.13 | | | | 0.20 | | | | |
After-tax charge related to fourth quarter 2008 restructuring actions and related charges ($82.0 million pre-tax). | | | 0.18 | | | | — | | | | | | | 0.18 | | | | — | | | | |
Gains from net reduction in income tax reserves and discrete tax benefits | | | — | | | | (0.05 | ) | | | | | | (0.03 | ) | | | (0.07 | ) | | | |
After-tax gain on indemnity proceeds related to litigation matter ($12.5 million pre-tax) | | | — | | | | — | | | | | | | — | | | | (0.02 | ) | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Adjusted Diluted Net Earnings Per Share from Continuing Operations (Non-GAAP) | | $ | 1.11 | | | $ | 1.12 | | | -0.9 | % | | $ | 4.23 | | | $ | 3.83 | | | 10.4 | % |
| | | | | | | | | | | | | | | | | | | | | | |
7
Danaher Corporation
Supplemental Reconciliation of Revenue Growth (GAAP) to Revenue Growth from Existing Businesses (Non-GAAP)
Three Months Ended December 31, 2008 and December 31, 2007
| | | | | | |
| | Three Months Ended December 31, 2008 vs. Comparable 2007 Period | | | Year Ended December 31, 2008 vs. Comparable 2007 Period | |
Components of Sales Growth | | | | | | |
| | |
Existing Businesses | | -1.0 | % | | 2.5 | % |
Acquisitions | | 6.0 | % | | 10.5 | % |
Impact of currency translation | | -4.0 | % | | 2.0 | % |
| | | | | | |
Total | | 1.0 | % | | 15.0 | % |
| | | | | | |
Notes to Non-GAAP Reconciliation Schedule
General
In addition to the results provided in this release in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”), the Company has provided the following non-GAAP measures:
(1) Adjusted net earnings from continuing operations for the three months and year ended December 31, 2008 and December 31, 2007 and adjusted net earnings from continuing operations per diluted share for the three months and year ended December 31, 2008 and December 31, 2007. These measures are calculated on a basis which:
| • | | in the 2008 period, exclude (a) certain non-cash charges related to the acquisition of Tektronix, Inc. for fair value adjustments to recorded inventory and deferred revenue balances, (b) gains related to a reduction of income tax reserves and discrete tax benefits and (c) charges related to fourth quarter 2008 restructuring actions and related charges; and |
| • | | in the 2007 period, exclude (a) gains related to a reduction of income tax reserves and discrete tax benefits, and (b) the gain on indemnity proceeds received in connection with a litigation matter and (c) certain non-cash charges for purchased in-process research and development and fair value adjustments to recorded inventory and deferred revenue balances related to the acquisition of Tektronix. |
The Company also discloses the year-over-year percentage change in these non-GAAP measures. Collectively, these non-GAAP measures are referred to as the “non-GAAP earnings measures”.
(2) Core revenue growth from existing businesses (presented on a stand-alone basis), which is defined as revenue growth from businesses that have been owned for one year or more, excluding the effects of foreign currency fluctuations.
The non-GAAP measures should be considered in addition to, and not as a replacement for or superior to, the comparable GAAP measures. Danaher’s non-GAAP measures may be defined differently than similar non-GAAP measures that are used by other companies.
Non-GAAP earnings measures and revenue growth from existing businesses
Danaher’s management believes that the non-GAAP earnings measures and revenue growth from existing businesses reflect additional ways of viewing aspects of Danaher’s operations that, when viewed with and reconciled to the corresponding GAAP measures, provide a more complete understanding of Danaher’s results of
8
operations and help identify underlying trends in Danaher’s business. The items that have been excluded from the non-GAAP earnings measures have been excluded because items of this nature and size occur with inconsistent frequency and for reasons that may be unrelated to Danaher’s commercial performance during the period, and we believe are not indicative of Danaher’s ongoing operating costs or gains in a given period. Similarly, revenue growth from existing businesses excludes items that are not completely under management’s control, such as the impact of changes in foreign currency exchange rates, and items that do not reflect the underlying growth of the company, such as acquisition and divestiture activity.
Danaher’s management uses these non-GAAP measures in assessing current performance against prior period performance and against forecasted performance, in forecasting financial results for future periods, and in making decisions about internal budgets, resource allocation and financial goals for its business units. Danaher’s management believes that these non-GAAP measures help investors and others, if they so choose, in understanding and evaluating Danaher’s current operating performance and future prospects in the same manner as management does. In addition, Danaher believes that analysts and others in the investment community use these non-GAAP measures to assess Danaher’s performance against prior period performance and against forecasted performance, compare Danaher’s performance to the performance of our peer companies, identify trends in Danaher’s performance and provide estimates of future performance.
A general limitation of these non-GAAP measures is that use of these measures (as compared to the related GAAP measures of net earnings from continuing operations, revenue and revenue growth) may reduce comparability with other companies who may calculate similar non-GAAP measures differently. A particular limitation of the non-GAAP earnings measures is that they exclude charges that can significantly affect Danaher’s results of operations and that may recur in the course of Danaher’s business (though at times and in amounts that may be difficult to predict). Similarly, a particular limitation of revenue growth from existing businesses is that it excludes items that can significantly impact our revenues. Danaher management compensates, and believes that investors should compensate, for these and other limitations of these non-GAAP measures by also considering Danaher’s financial results as determined in accordance with GAAP, including the GAAP measures described above in this paragraph.
9